Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12618001972213
ACTRN12618001972213
Completed
N/A

Attention deficit hyperactivity disorder, developmental coordination disorder, and the cognitive orientation to daily occupational performance approach: Is there a role for diagnostic profiling and treatment to improve mental health outcomes?

a Trobe University0 sites19 target enrollmentDecember 6, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAttention Deficit Hyperactivity DisorderDevelopmental Coordination DisorderMental Health - Other mental health disordersPhysical Medicine / Rehabilitation - Occupational therapy

Overview

Phase
N/A
Intervention
Not specified
Conditions
Attention Deficit Hyperactivity Disorder
Sponsor
a Trobe University
Enrollment
19
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 6, 2018
End Date
November 16, 2019
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
a Trobe University

Eligibility Criteria

Inclusion Criteria

  • •\- aged between 8\-12 years
  • •\- must have a pre\-existing diagnosis of ADHD
  • •\- current pharmacotherapy treatment for ADHD
  • •\- current Paediatrician
  • •\- if CO\-OP is used in Study B with a participant also diagnosed with DCD in Study A, an additional inclusion criteria applies for cognition (have adequate cognitive ability to participate in the intervention program (the child can attend and understand the strategies to be used in the CO\-OP Approach).

Exclusion Criteria

  • •\- clients without a pre\-existing diagnosis of ADHD
  • •\- pre\-exisiting motor disorder (as precludes a potential diagnosis of DCD)
  • •\- identified intellectual disability
  • •\- clients with ADHD currently unmedicated
  • •\- clients outside of Northern Tasmania
  • •\- cannot proceed to Study B if criteria for DCD not met in Study A.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
N/A
Attention Deficit Hyperactivity Disorder (ADHD) and opioid maintenance therapy.A randomized, placebo-controlled study of the efficacy of atomoxetine for treating adult ADHD in patients receiving opioid maintenance therapyPatients will be recruited from out-patient clinics treating opioid dependent patients with buprenorphine or methadone maintenance therapy. Patients will be screened for ADHD symptoms. Based on the screen results, patients will undergo medical and psychiatric assessment to identify those meeting the criteria for adult ADHD. Patients diagnosed with comorbid ADHD and opioid dependence will then be randomized into atomoxetine and placebo study groups.MedDRA version: 12.1Level: LLTClassification code 10064104Term: ADHD
EUCTR2010-019981-94-FIHUS/ Neuropsykiatrian poliklinikka30
Completed
Phase 1
erofeeback Training (NFT) of ADHD child at homeADHDADHD hyperactiveD046650
JPRN-jRCT1030220201Tazaki Miyako8
Not Yet Recruiting
Phase 3
Identification of Attention Deficit Hyperactivity Disorder using Parent-Teacher administered ADHD Rating Scale-IV among Pre-school going children to know the prevalence of this disorder in Belagavi city.
CTRI/2023/07/054991KAHER Institute Of Physiotherapy
Recruiting
Phase 2
Attention Defficity Hyperactivity Disorder and fMRI neurofeedback: A randomized controlled trial on the effects of self-modulating anterior cingulate cortex activation levels.
NL-OMON37512niversitair Medisch Centrum Sint Radboud
Completed
Phase 3
Imaging the influence and interaction of genes and stimulant medication on attention in Attention Deficit Hyperactivity Disorder (ADHD).
ACTRN12610000652077Dr. Tim Silk36